VHFC partner, Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected…
Kristian AndersenMarch 26, 2018
With a new $15 million grant, VHFC scientists at Scripps Research are gearing up for…
Kristian AndersenFebruary 27, 2018
The National Institutes of Health has awarded Tulane University more than $12 million to test…
adminJuly 12, 2017
A team of scientists at Scripps Research (Scripps Research) in La Jolla, California has published…
adminJune 5, 2017
Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases,…
adminDecember 13, 2016
Abstract - Lassa fever is a significant health threat to West African human populations with…
adminOctober 1, 2016
Opens Advanced Product Development Center in Colorado GERMANTOWN, MD AND DENVER – August 22, 2016…
adminAugust 22, 2016
Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The epitopes of…
Kristian AndersenMay 18, 2016
In a large multi-disciplinary collaboration, researchers from the Viral Hemorrhagic Fever Consortium (VHFC) have published…
Kristian AndersenAugust 13, 2015
